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Abstract
We describe herein 2 patients who developed Vogt-Koyanagi-Harada syndrome in the course
of renal biopsy-proven immunoglobulin A (IgA) nephropathy. A 61-year-old man with an 11-
year history of IgA nephropathy and a 16-year history of thyroiditis, and a 56-year-old man with
a 5-year history of IgA nephropathy developed Vogt-Koyanagi-Harada syndrome. At the time
of the eye disease presentation, IgA nephropathy was stable without corticosteroids in both pa-
tients. Vogt-Koyanagi-Harada syndrome was successfully treated with intravenous administration
of prednisolone tapered from 200 mg daily. Vogt-Koyanagi-Harada syndrome is associated with
IgA nephropathy, suggesting a similar autoimmune mechanism for both diseases.
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ogt-Koyanagi-Harada syndrome is a bilateral,  
diﬀ use granulomatous uveitis associated with 
poliosis,  vitiligo,  alopecia,  and central nervous sys-
tem and auditory signs [1].  Autoimmune mechanisms,  
probably directed against melanocytes,  are considered 
to underlie the inﬂ ammation [1].  Idiopathic immuno-
globulin A (IgA) nephropathy is the most common 
glomerulonephritis and is characterized by the varying 
extent of mesangial proliferation and mesangial 
immune complex deposition,  consisting of IgA as the 
predominant or codominant immunoglobulin type [2].  
We encountered 2 patients who developed Vogt-
Koyanagi-Harada syndrome in the long course of IgA 
nephropathy.
Case Reports
　 Case 1. A 61-year-old man noticed blurred 
vision and eye pain in both eyes,  together with head-
ache,  occurring for the past few months.  The best-
corrected visual acuity was 0.6 in the right eye and 1.0 
in the left eye.  He showed 2＋aqueous cells,  1＋ﬁ ne 
keratic precipitates,  and hyperemic,  swollen optic 
discs in both eyes (Fig.  1).  The fundi of both eyes 
appeared depigmented,  characteristic of Vogt-
Koyanagi-Harada syndrome (Fig.  1).  Fluorescein 
angiography disclosed marked leakage from the optic 
discs as well as dotty leakage points from the retinal 
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pigment epithelium in the posterior pole of both eyes 
(Fig.  1).
　 The patient had been diagnosed with IgA nephrop-
athy by renal biopsy 11 years previously at another 
hospital (Fig.  2).  Dominant IgA deposition was found 
in the mesangium by immunohistochemistry,  and elec-
tron dense deposits were observed in the mesangial 
and paramesangial areas by electron microscopy.  
Based on low activity of IgA nephropathy,  he had 
been followed without treatment and had been showing 
306 Acta Med.  Okayama　Vol.  61,  No.  5Matsuo et al.
Fig. 1　 Case 1,  a 61-year-old man,  as presented a few months after the onset of eye symptoms.  Fundus photographs (top) and ﬂ uores-
cein angiograms (bottom) in the late phase.  The right eye (left column) and the left eye (right column).  Both fundi appear depigmented,  
and angiograms show dye leakage from the optic discs as well as multiple weak leakage points from the retinal pigment epithelium,  char-
acteristic of Vogt-Koyanagi-Harada syndrome in the chronic stage.
A B
Fig. 2　 Case 1.  Photomicrographs of glomerular specimens obtained by renal biopsy 11 years before the onset of Vogt-Koyanagi-Harada 
disease.  Periodic acid Schiﬀ  (PAS) stain (A) and Periodic acid-methenamine-silver (PAM) stain (B),  showing low-grade mesangial cell 
proliferation.  Immunohistochemistry showed dominant IgA deposition in the mesangium (data not shown).
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a low level of proteinuria and an elevation of serum 
creatinine at 1.2ﾝ1.7 mg/dL.  At the time of the eye 
disease,  blood urea nitrogen was 24 mg/dL and serum 
creatinine was 1.56 mg/dL.  Hyperthyroidism had been 
diagnosed 16 years previously and had been con-
trolled well with propylthiouracil 50 mg daily.  The 
patient had also suﬀ ered from temporal arteritis 1 
year previously and treated with prednisolone tapered 
from 60 mg daily.
　 Intravenous administration of prednisolone 200 mg 
daily for 3 days was followed by its tapering to 
150 mg daily,  100 mg daily,  80 mg daily,  and 60 mg 
daily,  each for 3 days; the patient was then switched 
to oral prednisolone 30 mg daily,  which was then 
tapered and discontinued over a period of half a year.  
The inﬂ ammation subsided and the visual acuity 
became 1.0 in the right eye and 1.5 in the left eye.  
Systemically,  IgA nephropathy and hyperthyroidism 
were stable during this period.
　 Case 2. A 56-year-old man had noticed visual 
reduction in both eyes 2 days before examination.  The 
best-corrected visual acuity was 0.3 in the right eye 
and 0.09 in the left eye.  The aqueous cells and 
keratic precipitates were absent in both eyes.  He 
showed serous retinal detachment with slightly hyper-
emic optic discs in both eyes (Fig.  3).  Fluorescein 
angiography revealed multiple leakage points from the 
retinal pigment epithelial cells (Fig.  3),  typical of 
Vogt-Koyanagi-Harada syndrome.
　 The patient had developed proteinuria and hematu-
ria,  and had been diagnosed with IgA nephropathy by 
renal biopsy 5 years previously at another hospital 
(Fig.  4).  Since IgA nephropathy showed high activity,  
as evidenced by glomerular crescent formation,  he 
underwent one course of pulse corticosteroid therapy 
consisting of 3 days of intravenous methylpredniso-
lone 500 mg daily.  Oral prednisolone was then 
tapered from 40 mg daily and discontinued over a 
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Fig. 3　 Case 2,  a 56-year-old man.  Fundus photographs (top) and ﬂ uorescein angiograms (bottom) in the late phase.  The right eye (left 
column) and the left eye (right column).  Serous retinal detachment and multiple ﬂ uorescein leakage from the retinal pigment epithelium,  
typical of Vogt-Koyanagi-Harada syndrome at the early stage.
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period of half a year.  The patient had undergone 
bilateral tonsillectomy 2 years previously due to the 
deterioration of proteinuria.  At the time of the eye 
disease,  he showed a low level of proteinuria,  and the 
renal function was maintained at normal levels,  as 
evidenced from blood urea nitrogen levels of 13.1 mg/
dL and serum creatinine levels of 1.03 mg/dL,  with-
out treatment.
　 Intravenous administration of prednisolone 200 mg 
daily for 3 days was followed by its tapering to 
150 mg daily,  100 mg daily,  80 mg daily,  and 60 mg 
daily,  each for 3 days; the patient was then switched 
to oral prednisolone 30 mg daily,  which was then 
tapered and discontinued over a period of half a year.  
The visual acuity returned to 1.2 in both eyes.
Discussion
　 In the present 2 patients,  Vogt-Koyanagi-Harada 
disease was diagnosed based on the typical clinical 
features such as bilateral uveitis with serous retinal 
detachment in the posterior pole,  blurred and swollen 
optic discs,  and multiple leakage points from the reti-
nal pigment epithelium revealed by ﬂ uorescein angiog-
raphy [1].  The fundi of the ﬁ rst patient (Case 1) 
appeared depigmented,  and ﬂ uorescein dye leakage 
from the retinal pigment epithelium was weak in the 
chronic phase of the disease as he presented to us a 
few months after the onset of eye symptoms.  In con-
trast,  the second patient (Case 2) showed typical 
serous retinal detachment without aqueous inﬂ amma-
tion in the early phase of the disease.  Both patients 
showed sensorineural hearing loss in high pitch sound,  
also characteristic of Vogt-Koyanagi-Harada syn-
drome.
　 At the initial diagnosis of IgA nephropathy by renal 
biopsy,  Case 1 showed low disease activity with low-
grade mesangial cell proliferation,  while Case 2 
showed high disease activity with glomerular crescent 
formation.  Based on these clinical characteristics,  
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Fig. 4　 Case 2.  Photomicrographs of glomerular specimens obtained by renal biopsy 5 years before the onset of Vogt-Koyanagi-Harada 
disease.  Hematoxylin-eosin (HE) stain (A),  periodic acid Schiﬀ  (PAS) stain (B),  periodic acid-methenamine-silver (PAM) stain (C),  and 
immunohistochemical IgA stain (D),  showing mesangial cell proliferation,  glomerular loop thickening, and IgA deposition.
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Case 1 was followed without treatment while Case 2 
underwent pulse corticosteroid therapy with oral 
prednisolone tapering.  IgA nephropathy was stable in 
both patients without corticosteroid treatment at the 
time of the eye disease presentation.
　 Both Vogt-Koyanagi-Harada syndrome and IgA 
nephropathy are well known to be sometimes preceded 
by common cold-like symptoms.  Furthermore,  past 
reports have shown that Vogt-Koyanagi-Harada syn-
drome develops in association with autoimmune thy-
roiditis [3] and that IgA nephropathy occurs in asso-
ciation with autoimmune thyroiditis [4].  The ﬁ rst 
patient (Case 1) in this study developed Vogt-
Koyanagi-Harada syndrome in the background of IgA 
nephropathy and autoimmune thyroiditis,  consistent 
with these previous case reports [3,  4].
　 Vogt-Koyanagi-Harada syndrome is also reported 
to occur in association with ulcerative colitis [5].  The 
association of Vogt-Koyanagi-Harada syndrome with 
IgA nephropathy in 2 patients of the present study 
raises the possibility of a common underlying immune 
mechanism of these 2 diseases.  For instance,  both 
diseases show immunological abnormalities and have 
genetic predisposition such as familial occurrence and 
strong association with human leukocyte antigens 
(HLA) [1,  6].  In marked contrast with IgA nephrop-
athy,  no histopathological or immunohistochemical 
study of active lesions of Vogt-Koyanagi-Harada syn-
drome is available because the intraocular tissue can-
not be obtained by biopsy [1].  Such clinical limita-
tions surrounding Vogt-Koyanagi-Harada syndrome 
hinder detailed analysis of the underlying immune 
mechanism.  The association with IgA nephropathy 
might provide insight into the pathogenesis of Vogt-
Koyanagi-Harada syndrome.
　 At present,  the most common ophthalmic complica-
tion of IgA nephropathy reported thus far is scleritis 
[7].  To the best of our knowledge,  this study is the 
ﬁ rst to show an association between IgA nephropathy 
and Vogt-Koyanagi-Harada syndrome.  Until now,  
Vogt-Koyanagi-Harada syndrome has been reported to 
occur only in 2 patients with renal failure of unknown 
cause,  as described in separate case reports [8,  9].  
Vogt-Koyanagi-Harada syndrome might be added to the 
list of ophthalmic complications in patients with IgA 
nephropathy.
References
 1. Moorthy RS,  Inomata H and Rao NA: Vogt-Koyanagi-Harada syn-
drome.  Surv Ophthalmol (1995) 39: 265ﾝ292.
 2. Tomino Yｳ  Sakai H and Special Study Group (IgA Nephropathy) on 
Progressive Glomerular Disease: Clinical guidelines for immuno-
globulin A (IgA) nephropathy in Japan,  second version.  Clin Exp 
Nephrol (2003) 7: 93ﾝ97.
 3. Wiesli P,  Bernauer W and Furrer J: Headache and bilateral visual 
loss in a young hypothyroid Indian man.  J Endocrinol Invest (1999) 
22: 141ﾝ143.
 4. Enriquez R,  Sirvent AE,  Amoros F,  Andrada E,  Cabezuelo JB 
and Reyes A: IgA nephropathy and antoimmune thyroiditis.  Clin 
Nephrol (2002) 57: 406ﾝ407.
 5. Federman DG,  Kravetz JD,  Ruser CB,  Judson PH and Kirsner 
RS: Vogt-Koyanagi-Harada syndrome and ulcerative colitis.  South 
Med J (2004) 97: 169ﾝ171.
 6. Wada J,  Sugiyama H and Makino H: Pathogenesis of IgA 
nephropathy.  Semin Nephrol (2003) 23: 556ﾝ563.
 7. Nomoto Y,  Sakai H,  Endoh M and Tomino Y: Scleritis and IgA 
nephropathy.  Arch Intern Med (1980) 140: 783ﾝ785.
 8. Cavalli C,  Gobbi PG,  Colombo R,  Riccardi A,  Gorini M and 
Ascari E: A case of scleroderma with sclerodermic renal crisis and 
association with the Vogt-Koyanagi-Harada syndrome.  Presse Med 
(1985) 14: 1131ﾝ1134 (in French).
 9. Zalts R,  Hayek T,  Baruch Y,  Nakhoul F and Miller B: Vogt-
Koyanagi-Harada syndrome associated with renal failure: a case 
report.  J Nephrol (2006) 19: 225ﾝ228.
309Harada Disease and IgA NephropathyOctober 2007
5
Matsuo et al.: Vogt-Koyanagi-Harada Syndrome in Two Patients with Immunoglobulin
Produced by The Berkeley Electronic Press, 2007
